In "Reputation and Power," Daniel Carpenter masterfully narrates the ascent of the U.S. Food and Drug Administration (FDA) to become the titan of global regulatory entities, a journey marked by strategic cultivation of a formidable reputation. This book delves into the intricate dynamics that have empowered the FDA to stand at the forefront of pharmaceutical regulation, balancing its influence against the behemoths of the American drug industry and navigating the turbulent waters of political, corporate, and public expectations. Carpenter's analysis reveals how the FDA's perceived competence and vigilance have been its greatest assets, enabling it to shape the practices of medicine, business, and research both domestically and internationally. Through a meticulous examination of historical milestones—from the therapeutic revolution of the mid-20th century to the regulatory challenges posed by the AIDS epidemic and the complex landscape of modern drug approval—Carpenter illuminates the nuanced ways in which the FDA's authority has expanded and evolved. The narrative is enriched with insights into the agency's interactions with Congress, pharmaceutical giants, advocacy groups, and global counterparts, painting a comprehensive picture of its lasting impact on global health and safety standards. "Reputation and Power" is not only a testament to the enduring influence of the FDA's organizational image but also a critical exploration of the tension between regulatory power and the forces that seek to shape or limit it, offering invaluable perspective on the interplay between reputation, power, and policy in the highest echelons of government.